1. |
(.
|
2. |
周学平, 王红阳, 杨广顺, 等. MXR7基因的克隆及其在人正常和肿瘤组织中的表达 [J]. 中华实验外科杂志, 1999; 39(2)∶185.
|
3. |
Liu XE, Desmyter L, Gao CF, et al. Nglycomic changes in hepatocellular carcinoma patients with liver cirrhosis induced by hepatitis B virus [J]. Hepatology, 2007; 46(5)∶1426.
|
4. |
Müller C. Hepatocellular carcinoma——rising incidence, changing therapeutic strategies [J]. Wien Med Wochenschr, 2006; 156(13-14)∶404.
|
5. |
Poon RT. Optimal initial treatment for early hepatocellular carcinoma in patients with preserved liver function: transplantation or resection? [J]. Ann Surg Oncol, 2007; 14(2)∶541.
|
6. |
Chen XP, Qiu FZ, Wu ZD, et al. Longterm outcome of resection of large hepatocellular carcinoma [J]. Br J Surg, 2006; 93(5)∶600.
|
7. |
van der Bilt JD, Kranenburg O, Verheem A, et al. Selective portal clamping to minimize hepatic ischaemiareperfusion damage and avoid accelerated outgrowth of experimental colorectal liver metastases [J]. Br J Surg, 2006; 93(8)∶1015.
|
8. |
Chen XP, Qiu FZ, Wu ZD, et al. Effects of location and extension of portal vein tumor thrombus on longterm outcomes of surgical treatment for hepatocellular carcinoma [J]. Ann Surg Oncol, 2006; 13(7)∶940.
|
9. |
Shimada K, Sakamoto Y, Esaki M, et al. Analysis of prognostic factors affecting survival after initial recurrence and treatment efficacy for recurrence in patients undergoing potentially curative hepatectomy for hepatocellular carcinoma [J]. Ann Surg Oncol, 2007; 14(8)∶2337.
|
10. |
Gaggioli C, Hooper S, HidalgoCarcedo C, et al. Fibroblastled collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells [J]. Nat Cell Biol, 2007; 9(12)∶1392.
|
11. |
Wang T, Niu G, Kortylewski M, et al. Regulation of the innate and adaptive immune responses by Stat3 signaling in tumor cells [J]. Nat Med, 2004; 10(1)∶48.
|